We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The Irish tax authority Revenue Commissioners has issued a Notice of Amended Assessment (NoA) to Perrigo stating the company owes €1.64bn in tax from 2013 intellectual property sales by Elan Pharma, which was later acquired by Perrigo.....
A new analysis has revealed growing concern among the public over the financial state of the NHS, and support for raising taxes to help ensure that the service remains free at the point of use.
Several pharma companies have thrilled investors with their sunny predictions of how the new business-friendly tax package will boost investors’ fortunes this year—but not Amgen.